China Approves First Auditory Brainstem Implant for Congenital Deafness Treatment
- Published
- Source
- leaderobot.com
On October 20, the National Medical Products Administration approved the innovative 'auditory brainstem implant' developed by Professor Wu Hao's team and Zhejiang Nurotron Neuroelectronic Technology Co., Ltd. This Class III implantable device is China's first to perform electrical stimulation and neural signal extraction in the brainstem, addressing severe inner ear malformations and cochlear nerve absence.
The approval is significant as it fills a critical gap in congenital deafness interventions, expanding the eligible population for artificial hearing to include patients previously unable to benefit from cochlear implants. With a reported treatment effectiveness of 96.67% at 12 months post-activation, this device represents a major advancement in sensory reconstruction technology.
Looking ahead, the success of the Nurotron-WH-01A auditory brainstem implant could pave the way for further developments in invasive brain-computer interface technologies. The future of this technology will depend on clinical promotion, physician training, and insurance coverage to ensure widespread adoption and support for patients in need.
Original report
China's First Auditory Brainstem Implant Approved for Congenital Deafness Intervention
leaderobot.com · LeaderobotThis briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? Contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
More related news
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
Related Suppliers
lumen
Romania
Romanian startup building AI-powered smart glasses with LiDAR and haptic feedback to give blind and visually impaired users independent pedestrian navigation.
Hubei Jingchu Humanoid Robot Co., Ltd 湖北荆楚人形机器人有限公司
China
HUST-spinout Wuhan maker of direct-drive humanoid and quadruped robots, including the compact Jingchu Xiaochu and heavy-duty Jingchu Heibao.
Neuracle 博睿康科技（常州）股份有限公司
China
Chinese brain-computer interface company behind NEO, the world's first commercially approved implantable BCI, and NeuSen EEG acquisition systems.
Neurolutions
United States
US neurotech company founded 2007; developed IpsiHand, the first FDA-cleared non-invasive BCI for post-stroke upper limb motor rehabilitation.
Insight Medbotics
Canada
Hamilton, Ontario medical robotics company; developer of IGAR, the first FDA-cleared robot designed to operate inside an MRI scanner.
SS Innovations International Inc.
United States
India-headquartered surgical robotics firm offering the SSi Mantra robot, the only system approved for telesurgery, with 138+ installs across 8 countries.
NeuroDance 神舞科技
China
NeuroDance is a Chinese brain-computer interface company that launched ND1000 and ND8 EEG devices plus a NeuroAI cross-modal data platform in 2026.
OriginFlow 渊澈太初
China
Beijing startup founded 2025, based in Zhongguancun; builds OriginKitGen wearable hardware capturing video, motion, and 16-channel sEMG for robot training data.
WISAP Medical Technology GmbH
Germany
Brunnthal, Germany minimally invasive surgery device maker founded 1959; owned by China's Aohua Group since 2018, manufactures exclusively in Germany.
Xiangyu Medical Co., Ltd. 河南翔宇医疗设备股份有限公司
China
Anyang, China rehabilitation-device maker founded 2002; publicly listed on Shanghai's STAR Market under ticker 688626 since 2021.
Motorika USA Inc (part of Hobart Healthcare)
United States
US subsidiary of Israel's Motorika Medical; markets ReoAmbulator and ReoGo robotic rehabilitation systems for gait and upper-limb neurological therapy.
UCSD Healthcare Robotics Lab
United States
UCSD robotics research lab led by Prof. Laurel Riek; focuses on human-robot teaming, assistive care robots, and healthcare AI in clinical settings.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.
